NCT07612605尚未招募1 期
A Randomized Controlled Trial (RCT) of Yiqi Huoxue Jiedu Formula Combined With Bacteriophages in the Treatment of Severe Pneumonia Caused by Drug-resistant Gram-negative Bacilli
Chinese PLA General Hospital4 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2026年6月1日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 250
- 试验地点
- 4
研究概览
简要总结
Through a prospective randomized controlled trial, we systematically evaluate the effects of Yiqi Huoxue Jiedu Formula combined with bacteriophage therapy on the bacterial clearance rate, disease improvement rate and mortality rate in patients with severe pneumonia caused by drug-resistant bacteria, so as to clarify its clinical transformation value.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Triple (Participant, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 85 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients who meet the diagnostic criteria for severe pneumonia caused by drug-resistant Gram-negative bacilli and conform to the TCM syndrome differentiation of Qi deficiency, toxin accumulation and blood stasis syndrome;
- •Patients confirmed by rapid on-site microbiological evaluation (M-ROSE), clinical microbial culture and drug susceptibility testing (based on the drug susceptibility test results of our hospital or other Grade A tertiary hospitals) to be infected with multidrug-resistant Klebsiella pneumoniae, Acinetobacter baumannii or Pseudomonas aeruginosa;
- •Aged 18 to 85 years old;
- •Patients or their family members agree to cooperate with the collection of upper and lower respiratory tract specimens, consent to bronchoscopy plus bronchoalveolar lavage, and agree to receive nebulized inhalation of bacteriophage therapy;
- •Patients or their family members have fully read, understood and signed the informed consent form.
排除标准
- •Women who are pregnant or lactating;
- •Patients with immunodeficiency;
- •Patients receiving immunosuppressive therapy or suffering from immunodeficiency diseases;
- •Patients who have received mechanical ventilation for more than 60 days prior to enrollment;
- •Patients with active pulmonary tuberculosis, lung abscess, or Grade D chronic obstructive pulmonary disease (COPD);
- •Patients with incomplete sampling or clinical data;
- •Patients with known allergies to bacteriophage products or the components of Yiqi Huoxue Jiedu Formula;
- •Patients judged by the researchers as unsuitable for participation in this study.
研究者
Lixin Xie
Professor, Chief Physician
Chinese PLA General Hospital
研究点 (4)
Loading locations...
相似试验
尚未招募
1 期
A Randomized Controlled Trial (RCT) of Yiqi Huoxue Jiedu Formula Combined With Bacteriophages in the Treatment of Severe Pneumonia Caused by Drug-resistant Gram-negative BacilliPneumoniaNCT07338123Chinese PLA General Hospital240
已完成
不适用
Efficacy of XYZ for Withdrawal SyndromeSubstance Withdrawal SyndromeNCT07543809Chongqing Jiangbei Hospital of Traditional Chinese Medicine80
招募中
1 期
A Randomized Controlled Trial of Combined Bu Shen Yi Qi Decoction and Dehydroepiandrosterone (DHEA) for the Treatment of Ovarian Function DeclineDiminished Ovarian ReserveNCT07535983Jiangxi University of Traditional Chinese Medicine74
Unknown
不适用
A Randomised Pilot Trial Evaluating a Chinese Medicine Formula in the Treatment of Chronic Subjective TinnitusChiCTR2100046632Hong Kong Health and Medical Research Fund24
尚未招募
不适用
Huangjing Yangji Formula Combined With Resistance Training for SarcopeniaNCT07321535Wangjing Hospital, China Academy of Chinese Medical Sciences106